A
Alyssa C. M. Joynt
Researcher at University of Toronto
Publications - 4
Citations - 139
Alyssa C. M. Joynt is an academic researcher from University of Toronto. The author has contributed to research in topics: Chromosomal translocation & Exome sequencing. The author has an hindex of 1, co-authored 4 publications receiving 41 citations.
Papers
More filters
Journal ArticleDOI
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan,Alberto Delaidelli,Sujith K. Joseph,Kevin Bielamowicz,Kristen Fousek,Borja L. Holgado,Alex Manno,Dilakshan Srikanthan,Ahmed Z. Gad,Randy Van Ommeren,David Przelicki,Cory Richman,Vijay Ramaswamy,Craig Daniels,Jonelle G. Pallota,Tajana Douglas,Alyssa C. M. Joynt,Joonas Haapasalo,Carolina Nor,Maria C. Vladoiu,Claudia M. Kuzan-Fischer,Livia Garzia,Stephen C. Mack,Srinidhi Varadharajan,Matthew L. Baker,Liam D. Hendrikse,Michelle Ly,Kaitlin Kharas,Polina Balin,Xiaochong Wu,Lei Qin,Ning Huang,Ana Guerreiro Stucklin,A. Sorana Morrissy,Florence M.G. Cavalli,Betty Luu,Raul Suarez,Pasqualino De Antonellis,Antony Michealraj,Avesta Rastan,Meenakshi Hegde,Martin Komosa,Olga Sirbu,Sachin Kumar,Zied Abdullaev,Claudia C. Faria,Stephen Yip,Juliette Hukin,Uri Tabori,Cynthia Hawkins,Kenneth Aldape,Mads Daugaard,Mads Daugaard,John M. Maris,John M. Maris,Poul H. Sorensen,Nabil Ahmed,Michael D. Taylor +57 more
TL;DR: It is demonstrated that administration of these chimeric antigen receptor T cells into the cerebrospinal fluid, alone or in combination with azacytidine, is a highly effective therapy for multiple metastatic mouse models of group 3 medulloblastoma and PFA ependymoma, thereby providing a rationale for clinical trials of these approaches in humans.
Journal ArticleDOI
Genome sequencing for detection of pathogenic deep intronic variation: A clinical case report illustrating opportunities and challenges.
Susan Walker,Susan Walker,Sylvia Lamoureux,Tayyaba Khan,Alyssa C. M. Joynt,Melissa Bradley,Helen M. Branson,Melissa T. Carter,Melissa T. Carter,Robin Z. Hayeems,Lukasz Jagiello,Christian R. Marshall,M. Stephen Meyn,M. Stephen Meyn,Steven P. Miller,Diane Wilson,Stephen W. Scherer,Stephen W. Scherer,Susan Blaser,Kamiar Mireskandari,Gregory Costain +20 more
TL;DR: In this paper, a 7-year-old male with a similar presentation was found by research-based quad genome sequencing to have two novel splicing variants in trans in JAM3, including one deep intronic variant (NM_032801.4: c.256+1260G>C) not detectable by standard exome sequencing.
Journal ArticleDOI
Understanding genetic variants of uncertain significance
Journal ArticleDOI
A rare unbalanced translocation (trisomy 5q33.3-qter, monosomy 13q34-qter) results in growth hormone deficiency and brain anomalies.
Alyssa C. M. Joynt,Ashish R. Deshwar,Jessica Zon,Lucie Dupuis,Diane K. Wherrett,Roberto Mendoza-Londono +5 more
TL;DR: In this article, a second patient with a similar rearrangement arising from a paternal balanced translocation was described, and the patient was found to have global developmental delay, distinct facial features, short stature, growth hormone deficiency, delayed puberty, and brain anomalies including a small pituitary.